Details for Patent: 11,964,055
✉ Email this page to a colleague
Which drugs does patent 11,964,055 protect, and when does it expire?
Patent 11,964,055 protects NEXTSTELLIS and is included in one NDA.
This patent has sixty-five patent family members in forty countries.
Drugs Protected by US Patent 11,964,055
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mayne Pharma | NEXTSTELLIS | drospirenone; estetrol | TABLET;ORAL | 214154-001 | Apr 15, 2021 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,964,055
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3701944 | ⤷ Subscribe | PA2022508 | Lithuania | ⤷ Subscribe |
| European Patent Office | 3701944 | ⤷ Subscribe | PA2022508,C3701944 | Lithuania | ⤷ Subscribe |
| Australia | 2016280858 | ⤷ Subscribe | |||
| Australia | 2021203265 | ⤷ Subscribe | |||
| Australia | 2022283615 | ⤷ Subscribe | |||
| Australia | 2024201228 | ⤷ Subscribe | |||
| Brazil | 112017027229 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
